Adial Pharmaceuticals (ADIL) Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04 Aug 13, 2024 09:03AM
Adial Pharmaceuticals (ADIL) Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044 Jul 31, 2024 08:32AM